tm
Seeing Is Believing
tm
Seeing Is Believing
NMRA is currently covered by 5 analysts with an average price target of $14.66. This is a potential upside of $11.64 (385.43%) from yesterday's end of day stock price of $3.02.
Neumora Therapeutics's activity chart (see below) currently has 14 price targets and 22 ratings on display. The stock rating distribution of NMRA is 20% HOLD and 80% BUY.
Analysts average stock forecasts to be materialized ratio is 10% with an average time for these price targets to be met of 24.4 days.
Highest price target for NMRA is $29, Lowest price target is $7, average price target is $18.
Most recent stock forecast was given by TESSA ROMERO from JPMORGAN on 16-Sep-2025. First documented stock forecast 10-Oct-2023.
Currently out of the existing stock ratings of NMRA, 2 are a HOLD (20%), 8 are a BUY (80%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$15
1 months 15 days ago
(16-Sep-2025)
0/4 (0%)
$3.09 (25.94%)
Buy
8 months 17 days ago
(14-Feb-2025)
0/3 (0%)
$19.13 (175.99%)
Buy
$7
$4.37 (166.16%)
$18
9 months 25 days ago
(06-Jan-2025)
1/2 (50%)
$4.52 (182.26%)
122
Buy
$23
9 months 29 days ago
(02-Jan-2025)
0/5 (0%)
$12.22 (113.36%)
Buy
$29
$26.37 (1002.66%)
$29
11 months 9 days ago
(22-Nov-2024)
0/4 (0%)
$19.26 (197.74%)
What is NMRA (Neumora Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on NMRA (Neumora Therapeutics) with a proven track record?
Which analyst has the current lower performing score on NMRA (Neumora Therapeutics) with a proven track record?
Which analyst has the most public recommendations on NMRA (Neumora Therapeutics)?
Which analyst is the currently most bullish on NMRA (Neumora Therapeutics)?
Which analyst is the currently most reserved on NMRA (Neumora Therapeutics)?
